journal article·2019-11-12Open access

Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe2O4/silica/cisplatin nanocomposite formulation

B Rabindran Jermy, Vijaya Ravinayagam, Widyan A Alamoudi, Dana Almohazey, Hatim Dafalla, Lina Hussain Allehaibi, Abdulhadi Baykal, Muhammet S Toprak, Thirunavukkarasu Somanathan

Abstract

The combination of magnetic nanoparticles with a porous silica is a composite that has attracted significant attention for potential multifunctional theranostic applications. In this study, 30 wt % CuFe2O4 was impregnated into a matrix of monodispersed spherical hydrophilic silica (HYPS) nanoparticles through a simple dry impregnation technique. The chemotherapy drug cisplatin was loaded through electrostatic equilibrium adsorption over 24 h in normal saline solution. The presence of cubic spinel CuFe2O4 on HYPS was confirmed through powder X-ray diffraction (PXRD), Fourier transform infrared spectroscopy (FTIR) and diffuse reflectance UV–vis spectroscopy (DR UV–vis) analysis. The HYPS particles showed a surface area of 170 m2/g, pore size of 8.3 nm and pore volume of 0.35 cm3/g. The cisplatin/CuFe2O4/HYPS nanoformulation showed the accumulation of copper ferrite nanoparticles on the surface and in the pores of HYPS with a surface area of 45 m2/g, pore size of 16 nm and pore volume of 0.18 cm3/g. Transmission electron microscopy (TEM) and energy dispersive X-ray (EDX) mapping analysis showed the presence of homogeneous silica particles with nanoclusters of copper ferrite distributed on the HYPS support. Vibrating sample magnetometry (VSM) analysis of CuFe2O4/HYPS showed paramagnetic behavior with a saturated magnetization value of 7.65 emu/g. DRS UV–vis analysis revealed the functionalization of cisplatin in tetrahedral and octahedral coordination in the CuFe2O4/HYPS composite. Compared to other supports such as mesocellular foam and silicalite, the release of cisplatin using the dialysis membrane technique was found to be superior when CuFe2O4/HYPS was applied as the support. An in vitro experiment was conducted to determine the potential of CuFe2O4/HYPS as an anticancer agent against the human breast cancer cell line MCF-7. The results show that the nanoparticle formulation can effectively target cancerous cells and could be an effective tumor imaging guide and drug delivery system.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Magnetic Properties and Synthesis of Ferrites · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (21)

Show source-provided references
1. 10.2147/ijn.s14631510.2147/ijn.s146315 ↗
2. 10.3390/ijms1708119310.3390/ijms17081193 ↗
3. 10.1039/c7tb01963g10.1039/c7tb01963g ↗
4. 10.1016/j.jconrel.2016.11.03210.1016/j.jconrel.2016.11.032 ↗
5. 10.1007/s10948-018-4921-310.1007/s10948-018-4921-3 ↗
6. 10.1007/s10948-018-4733-510.1007/s10948-018-4733-5 ↗
7. 10.1016/j.jmmm.2011.10.01710.1016/j.jmmm.2011.10.017 ↗
8. 10.1021/jp711248h10.1021/jp711248h ↗
9. 10.3390/nano707015110.3390/nano7070151 ↗
10. 10.1039/c3cp54291b10.1039/c3cp54291b ↗
11. 10.1016/j.ceramint.2013.09.06310.1016/j.ceramint.2013.09.063 ↗
12. 10.1016/j.chemosphere.2007.01.08110.1016/j.chemosphere.2007.01.081 ↗
13. 10.1016/j.molcata.2016.11.00510.1016/j.molcata.2016.11.005 ↗
14. 10.1007/s13204-018-0786-910.1007/s13204-018-0786-9 ↗
15. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
16. 10.1016/j.jallcom.2014.02.01210.1016/j.jallcom.2014.02.012 ↗
17. 10.1016/j.msec.2017.02.01010.1016/j.msec.2017.02.010 ↗
18. 10.1103/physrevlett.80.18110.1103/physrevlett.80.181 ↗
19. 10.1016/j.micromeso.2014.02.03310.1016/j.micromeso.2014.02.033 ↗
20. 10.1016/j.ejphar.2014.07.02510.1016/j.ejphar.2014.07.025 ↗
21. 10.1038/onc.2011.38410.1038/onc.2011.384 ↗